Global private equity and venture capital news and research

Posts Tagged ‘Aptalis Pharma’

9 January 2014

TPG succeeds in $2.9bn Aptalis sale months after deal looked dead

drug-pharma-medical-healthcare TPG Capital has sold drugmaker Aptalis Pharma for $2.9bn to Forest Laboratories just months after the sale process looked to have stalled.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016